ALT5 Sigma Corporation Announces Participation at the Spartan Capital Investor Conference
ALT5 Sigma (NASDAQ:ALTS) announces its participation in Spartan Capital Securities' inaugural investor conference scheduled for November 4th at the Pierre Hotel in New York. The event will feature presentations from over 30 selected companies, including panel discussions, one-on-one meetings, and networking sessions. The conference, organized in partnership with B2i Digital, aims to facilitate interactions between companies and Spartan Capital's investor base. ALT5's CRO Vay Tham will present the company's growth strategy and market position to key capital market influencers.
ALT5 Sigma (NASDAQ:ALTS) annuncia la sua partecipazione alla prima conferenza degli investitori di Spartan Capital Securities, programmata per il 4 novembre presso il Pierre Hotel di New York. L'evento presenterà interventi di oltre 30 aziende selezionate, comprese discussioni in pannello, incontri uno a uno e sessioni di networking. La conferenza, organizzata in collaborazione con B2i Digital, ha l'obiettivo di facilitare le interazioni tra le aziende e la base di investitori di Spartan Capital. Il CRO di ALT5, Vay Tham, presenterà la strategia di crescita dell'azienda e la sua posizione di mercato ai principali influencer dei mercati di capitali.
ALT5 Sigma (NASDAQ:ALTS) anuncia su participación en la primera conferencia de inversores de Spartan Capital Securities, programada para el 4 de noviembre en el Hotel Pierre de Nueva York. El evento contará con presentaciones de más de 30 empresas seleccionadas, incluidas discusiones en panel, reuniones uno a uno y sesiones de networking. La conferencia, organizada en colaboración con B2i Digital, tiene como objetivo facilitar las interacciones entre las empresas y la base de inversores de Spartan Capital. El CRO de ALT5, Vay Tham, presentará la estrategia de crecimiento de la empresa y su posición en el mercado a los principales influenciadores del mercado de capitales.
ALT5 Sigma (NASDAQ:ALTS)는 11월 4일 뉴욕의 피에르 호텔에서 예정된 스파르탄 캐피탈 증권사의 첫 투자자 회의에 참여한다고 발표했습니다. 이 행사에는 30개 이상의 선정된 기업의 발표가 포함되며, 패널 토론, 일대일 회의 및 네트워킹 세션이 진행됩니다. B2i Digital과 협력하여 조직된 이 회의는 기업과 스파르탄 캐피탈의 투자자 간의 상호작용을 촉진하는 것을 목표로 합니다. ALT5의 CRO인 Vay Tham은 회사의 성장 전략과 시장 위치를 주요 자본 시장 인플루언서들에게 발표할 예정입니다.
ALT5 Sigma (NASDAQ:ALTS) annonce sa participation à la première conférence des investisseurs de Spartan Capital Securities, prévue pour le 4 novembre à l'Hôtel Pierre à New York. L'événement comprendra des présentations de plus de 30 entreprises sélectionnées, y compris des tables rondes, des rencontres individuelles et des sessions de réseautage. La conférence, organisée en partenariat avec B2i Digital, vise à faciliter les interactions entre les entreprises et la base d'investisseurs de Spartan Capital. Le CRO d'ALT5, Vay Tham, présentera la stratégie de croissance de l'entreprise et sa position sur le marché aux principaux influenceurs des marchés de capitaux.
ALT5 Sigma (NASDAQ:ALTS) gibt seine Teilnahme an der ersten Investorenkonferenz von Spartan Capital Securities bekannt, die am 4. November im Pierre Hotel in New York stattfinden wird. Die Veranstaltung wird Präsentationen von über 30 ausgewählten Unternehmen umfassen, darunter Podiumsdiskussionen, Einzelgespräche und Networking-Sitzungen. Die Konferenz, die in Partnerschaft mit B2i Digital organisiert wird, zielt darauf ab, Interaktionen zwischen den Unternehmen und der Investorengruppe von Spartan Capital zu erleichtern. Der CRO von ALT5, Vay Tham, wird die Wachstumsstrategie des Unternehmens und seine Marktposition den wichtigsten Influencern der Kapitalmärkte präsentieren.
- None.
- None.
Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement
LAS VEGAS, NV / ACCESSWIRE / October 30, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), is proud to announce its participation in Spartan Capital Securities, LLC's inaugural investor conference on November 4th at the prestigious Pierre Hotel in New York.
This participation aligns with our commitment to engage with industry leaders and investors. Our presentation will offer insight into our company's growth strategy and market position.
Presenting Company Brief Description.
Vay Tham, ALT5's CRO commented, "We are pleased to be invited and to present at Spartan Capital's inaugural investor conference. This event provides an excellent platform to showcase our company and keep the key influencers in the capital markets apprised of our accomplishments and future plans."
The conference, organized in partnership with B2i Digital, a leading digital marketing firm specializing in investor communications, will feature presentations from over 30 carefully selected companies. The event will include panel discussions, one-on-one meetings, and networking sessions to maximize interactions between interested parties and presenting companies.
"We're privileged to welcome ALT5 Sigma Corporation to this pivotal event and showcase their accomplishment on b2idigital.com and with our 950K+ sophisticated investor community across social media," added David Shapiro, CEO of B2i Digital.
John D. Lowry, Founder and Chief Executive Officer of Spartan Capital Securities, LLC, stated, "Our inaugural investor conference commemorates Spartan Capital's 17 years as a trusted leader in the capital markets. It underscores our commitment to building meaningful connections between client companies and our sophisticated investor base. The Pierre is an ideal venue for our clients to explore capital formation opportunities and strengthen relationships."
For more information about the conference and registration details, please visit Spartan Capital's conference page.
About ALT5 Sigma Corporation
The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.
Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US
ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.
Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Media Contact Investor Relations
1-800-400-2247
Presenting Company [ALT5 Sigma] Contact Information
Vay Tham - CRO & President, vay@alt5sigma.com
Jerome Cliché - Corporate Advisor, Financial Communications, jerome@alt5sigma.com
About B2i Digital, Inc.
B2i Digital, Inc. leverages the latest digital marketing technologies to tell a company's story to retail investors, institutional investors, and research analysts. B2i Digital creates robust profiles for companies on its platform, b2idigital.com, and launches targeted digital marketing campaigns to bring the most relevant investors to each company based on its sector, stage in its capital markets evolution, and overall company story. The company was founded in 2021 by David Shapiro, previously the Chief Marketing Officer for Maxim Group LLC and its investor awareness platform, M-Vest.com.
B2i Digital Contact Information:
David Shapiro
Chief Executive Officer
B2i Digital, Inc.
https://b2idigital.com
212.579.4844 Office
david@b2idigital.com
https://www.linkedin.com/in/davidshapironyc
https://www.linkedin.com/company/b2i-digital
https://www.facebook.com/b2idigital
https://www.instagram.com/b2i_digital
https://www.youtube.com/@b2idigital
https://www.pinterest.com/b2idigital
https://www.tiktok.com/@b2idigital
https://stocktwits.com/B2iDigital
https://www.reddit.com/r/b2i_digital
https://www.threads.net/@b2i_digital
About Spartan Capital Securities, LLC
Spartan Capital Securities, LLC, is a premier full-service financial firm offering expert investment advice to high-net-worth individuals and institutional clients. Known for its extensive market knowledge, strategic risk management, and personalized service, Spartan Capital and CEO John Lowry exemplify integrity and professionalism in the financial services industry.
Spartan Capital Securities Contact:
Kim Monchik
45 Broadway, 19th Floor
New York, NY 10006
https://spartancapital.com
212.293.0123
Info@spartancapital.com
https://www.linkedin.com/company/spartan-capital-securities-llc/
Contact Information
Investor Relations
ir@alt5sigma.com
1-800-400-2247
SOURCE: ALT 5 Sigma
View the original press release on accesswire.com
FAQ
When is ALT5 Sigma (ALTS) presenting at the Spartan Capital Investor Conference?
How many companies will present at the Spartan Capital Conference where ALTS is participating?
Who will represent ALT5 Sigma (ALTS) at the Spartan Capital Conference?
